Evidence map›Paper›PMID 19492416›Full record

ArticleJournal of cellular physiology2009

Atypical protein kinase C activity is required for extracellular matrix degradation and invasion by Src-transformed cells.

Elena M Rodriguez, Elizabeth E Dunham, G Steven Martin

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Control of MT1-MMP transport by atypical PKC during breast-cancer progression.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  8. Review
  9. Review
  10. Review
  11. Atypical protein kinase C in cell motility.Cellular and molecular life sciences : CMLS · 2013
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elena M RodriguezDepartment of Molecular and Cell Biology, University of California at Berkeley, Berkeley, California 94720-3204, USA.
Elizabeth E Dunham
G Steven Martin
University of California, Berkeley · US

Funding

GENETICS OF RNA TUMOR VIRUSESR37CA017542 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARTIN, G STEVEN · 1990 to 2010
$4.0M
GENETICS OF RNA TUMOR VIRUSESR01CA017542 · NCI · UNIVERSITY OF CALIFORNIA BERKELEY · PI MARTIN, G STEVEN · 1985 to 2002
$1.1M
NCI NIH HHS CA17542NCI NIH HHS R01 CA017542NCI NIH HHS R37 CA017542
6 · The paper itself

Abstract

Atypical protein kinase C (aPKC) isoforms have been shown to mediate Src-dependent signaling in response to growth factor stimulation. To determine if aPKC activity contributes to the transformed phenotype of cells expressing oncogenic Src, we have examined the activity and function of aPKCs in 3T3 cells expressing viral Src (v-Src). aPKC activity and tyrosine phosphorylation were found to be elevated in some but not all clones of mouse fibroblasts expressing v-Src. aPKC activity was inhibited either by addition of a membrane-permeable pseudosubstrate, by expression of a dominant-negative aPKC, or by RNAi-mediated knockdown of specific aPKC isoforms. aPKC activity contributes to morphological transformation and stress fiber disruption, and is required for migration of Src-transformed cells and for their ability to polarize at the edge of a monolayer. The lambda isoform of aPKC is specifically required for invasion through extracellular matrix in Boyden chamber assays and for degradation of the extracellular matrix in in situ zymography assays. Tyrosine phosphorylation of aPKClambda is required for its ability to promote cell invasion. The defect in invasion upon aPKC inhibition appears to result from a defect in the assembly and/or function of podosomes, invasive adhesions on the ventral surface of the cell that are sites of protease secretion. aPKC was also found to localize to podosomes of v-Src transformed cells, suggesting a direct role for aPKC in podosome assembly and/or function. We conclude that basal or elevated aPKC activity is required for the ability of Src-transformed cells to degrade and invade the extracellular matrix.

Indexed as

Cell MovementAnimalsCell Line, TransformedCell PolarityClone CellsEnzyme ActivationExtracellular MatrixFibroblastsIsoenzymesMiceOncogene Protein pp60(v-src)PhosphorylationPhosphotyrosineProtein Kinase CProtein Kinase C-lambdaProtein Kinase C zetaIsoenzymesOncogene Protein pp60(v-src)PhosphotyrosinePKC-3 proteinProtein Kinase CProtein Kinase C-lambdaProtein Kinase C zeta

Identifiers

PMID19492416
PMCPMC2782718
OpenAlexW1989095332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.